Encision Inc (ECIA)
OTHER OTC:ECIA
Want to see ECIA full AI Analyst Report?
ECIA Stock Chart & Stats
$0.14
$0.03(7.14%)
At close: 4:00 PM EST
$0.14
$0.03(7.14%)
Day’s Range― - ―
52-Week Range$0.09 - $0.40
Previous CloseN/A
Volume5.10K
Average Volume (3M)16.18K
Market Cap
$3.39M
Enterprise Value$3.95M
Total Cash (Recent Filing)$71.73K
Total Debt (Recent Filing)$1.53M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding16,879,644
10 Day Avg. Volume10,380
30 Day Avg. Volume16,177
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)3.45
Price to Sales (P/S)0.87
P/FCF Ratio-42.25
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit1.19
Enterprise Value/Ebitda-16.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginA sustained ~53% gross margin indicates durable product economics and pricing power in its medical-instruments niche. That margin buffer supports long-term viability even if operating costs fluctuate, enabling a path to profitability if SG&A and R&D are better aligned with revenue.
Proven Ability To Generate Cash In Some YearsHistorical episodes of positive operating and free cash flow show the business can be cash generative under the right conditions. This indicates the cost base and revenue model can scale to produce cash, implying operational levers exist to restore persistent cash generation over months to years.
Deregistration To Reduce Compliance CostsVoluntary SEC deregistration is a structural change reducing recurring compliance and reporting costs. Saved expenses can be redeployed to operations or liquidity preservation, lowering fixed overhead and improving runway for a small-cap business over the medium term, albeit with trade-offs.
Bears Say
TTM Balance-sheet Red FlagZero equity and negative total assets on a TTM basis materially weaken the financial cushion. This eroded solvency increases bankruptcy and creditor risk, constrains borrowing or supplier credit, and magnifies the consequences of further losses over the medium term.
Negative Cash-flow TrendSustained negative operating and free cash flow on a TTM basis signals persistent cash burn. Over several months this pressures liquidity, can force dilutive financing or asset sales, and limits the company's ability to invest in growth or maintain critical R&D and manufacturing capabilities.
Contracting Revenue With Ongoing LossesDeclining revenues coupled with negative net and EBIT/EBITDA margins indicate structural demand or competitive issues. This pattern undermines scale economics and makes margin recovery harder, increasing the risk that occasional profitable years remain episodic rather than sustainable.
Encision News
ECIA FAQ
What was Encision Inc’s price range in the past 12 months?
Encision Inc lowest stock price was $0.09 and its highest was $0.40 in the past 12 months.
What is Encision Inc’s market cap?
Encision Inc’s market cap is $3.39M.
When is Encision Inc’s upcoming earnings report date?
Encision Inc’s upcoming earnings report date is Aug 11, 2026 which is in 81 days.
How were Encision Inc’s earnings last quarter?
Currently, no data Available
Is Encision Inc overvalued?
According to Wall Street analysts Encision Inc’s price is currently Overvalued.
Does Encision Inc pay dividends?
Encision Inc does not currently pay dividends.
What is Encision Inc’s EPS estimate?
Encision Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Encision Inc have?
Encision Inc has 16,879,644 shares outstanding.
What happened to Encision Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Encision Inc?
Currently, no hedge funds are holding shares in ECIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
Technical Analysis
Ownership Overview
53.49% Insiders
6.29% Other Institutional Investors
40.21% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---